S113: IMPACT OF IKZF1 DELETION IN RELAPSED AND/OR REFRACTORY B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA TREATED WITH CD19-CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY

Detalles Bibliográficos
Autores principales: Cai, Zihong, Zhang, Ting, Chen, Suning, Huang, Liang, Liu, Qifa, Zhou, Hongsheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Oral Sessions
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428479/
http://dx.doi.org/10.1097/01.HS9.0000967364.68535.18
_version_ 1785090479974514688
author Cai, Zihong
Zhang, Ting
Chen, Suning
Huang, Liang
Liu, Qifa
Zhou, Hongsheng
author_facet Cai, Zihong
Zhang, Ting
Chen, Suning
Huang, Liang
Liu, Qifa
Zhou, Hongsheng
author_sort Cai, Zihong
collection PubMed
description
format Online
Article
Text
id pubmed-10428479
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104284792023-08-17 S113: IMPACT OF IKZF1 DELETION IN RELAPSED AND/OR REFRACTORY B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA TREATED WITH CD19-CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY Cai, Zihong Zhang, Ting Chen, Suning Huang, Liang Liu, Qifa Zhou, Hongsheng Hemasphere Oral Sessions Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10428479/ http://dx.doi.org/10.1097/01.HS9.0000967364.68535.18 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Oral Sessions
Cai, Zihong
Zhang, Ting
Chen, Suning
Huang, Liang
Liu, Qifa
Zhou, Hongsheng
S113: IMPACT OF IKZF1 DELETION IN RELAPSED AND/OR REFRACTORY B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA TREATED WITH CD19-CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY
title S113: IMPACT OF IKZF1 DELETION IN RELAPSED AND/OR REFRACTORY B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA TREATED WITH CD19-CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY
title_full S113: IMPACT OF IKZF1 DELETION IN RELAPSED AND/OR REFRACTORY B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA TREATED WITH CD19-CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY
title_fullStr S113: IMPACT OF IKZF1 DELETION IN RELAPSED AND/OR REFRACTORY B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA TREATED WITH CD19-CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY
title_full_unstemmed S113: IMPACT OF IKZF1 DELETION IN RELAPSED AND/OR REFRACTORY B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA TREATED WITH CD19-CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY
title_short S113: IMPACT OF IKZF1 DELETION IN RELAPSED AND/OR REFRACTORY B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA TREATED WITH CD19-CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY
title_sort s113: impact of ikzf1 deletion in relapsed and/or refractory b-cell acute lymphoblastic leukemia treated with cd19-chimeric antigen receptor t-cell therapy
topic Oral Sessions
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428479/
http://dx.doi.org/10.1097/01.HS9.0000967364.68535.18
work_keys_str_mv AT caizihong s113impactofikzf1deletioninrelapsedandorrefractorybcellacutelymphoblasticleukemiatreatedwithcd19chimericantigenreceptortcelltherapy
AT zhangting s113impactofikzf1deletioninrelapsedandorrefractorybcellacutelymphoblasticleukemiatreatedwithcd19chimericantigenreceptortcelltherapy
AT chensuning s113impactofikzf1deletioninrelapsedandorrefractorybcellacutelymphoblasticleukemiatreatedwithcd19chimericantigenreceptortcelltherapy
AT huangliang s113impactofikzf1deletioninrelapsedandorrefractorybcellacutelymphoblasticleukemiatreatedwithcd19chimericantigenreceptortcelltherapy
AT liuqifa s113impactofikzf1deletioninrelapsedandorrefractorybcellacutelymphoblasticleukemiatreatedwithcd19chimericantigenreceptortcelltherapy
AT zhouhongsheng s113impactofikzf1deletioninrelapsedandorrefractorybcellacutelymphoblasticleukemiatreatedwithcd19chimericantigenreceptortcelltherapy

Ejemplares similares